Fairpointe Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $312K | Sell |
4,945
-2,291
| -32% | -$145K | 0.47% | 58 |
|
|
2020
Q4 | $449K | Buy |
7,236
+100
| +1% | +$6.21K | 0.08% | 61 |
|
|
2020
Q3 | $430K | Hold |
7,136
| – | – | 0.07% | 62 |
|
|
2020
Q2 | $420K | Buy |
7,136
+129
| +2% | +$7.59K | 0.06% | 64 |
|
|
2020
Q1 | $391K | Sell |
7,007
-2,133
| -23% | -$119K | 0.06% | 63 |
|
|
2019
Q4 | $587K | Sell |
9,140
-1,850
| -17% | -$119K | 0.05% | 61 |
|
|
2019
Q3 | $557K | Buy |
10,990
+3,200
| +41% | +$162K | 0.03% | 61 |
|
|
2019
Q2 | $353K | Buy |
7,790
+1,300
| +20% | +$58.9K | 0.01% | 71 |
|
|
2019
Q1 | $310K | Buy |
6,490
+400
| +7% | +$19.1K | 0.01% | 70 |
|
|
2018
Q4 | $317K | Buy |
6,090
+1,000
| +20% | +$52.1K | 0.01% | 75 |
|
|
2018
Q3 | $316K | Sell |
5,090
-1,200
| -19% | -$74.5K | 0.01% | 72 |
|
|
2018
Q2 | $348K | Buy |
6,290
+1,990
| +46% | +$110K | 0.01% | 70 |
|
|
2018
Q1 | $272K | Buy |
+4,300
| New | +$272K | 0.01% | 77 |
|